| PP100423002715 |
EmphyCorp, Inc. |
N115 |
sodium pyruvate |
To regulat.. |
Cystic fib.. |
NDA, NDA, Phase III completed, Phase III, Phase II completed, Phase II completed |
View Details
|
| PP090115002906 |
EyeGate Pharmaceuticals, Inc. |
EGP-437 |
dexamethasone phosphate |
|
Anterior u.. |
NDA, Phase II, Phase III completed, Phase I, NDA |
View Details
|
| PP090415003035 |
Kyntra Bio, Inc. (since Jan 2026), FibroGen, Inc. |
Evrenzo, FG-4592, ASP1517 |
recombinant human collagen type III, roxadustat |
A hypoxia-.. |
Anemia in .. |
Approved, Phase III, Phase III |
View Details
|
| PP130802011681 |
ESTEVE |
MR309, E-52862 |
|
A selectiv.. |
Neuropathi.. |
Phase II completed, Phase II completed |
View Details
|
| PP130802011684 |
ESTEVE |
Sanfilippo |
Adeno-associated virus (AAV) vector containing the human sulfamidase(heparan N-sulfatase) gene (AAV-sulfamidase) |
|
Mucopolysa.. |
Preclinical |
View Details
|
| PP140603012180 |
Enzychem Lifesciences Corporation |
EC18 |
PLAG |
A PRR endo.. |
Chemoradia.. |
Phase II completed, Phase II, Phase I completed, Phase II, Phase II |
View Details
|
| PP160726014536 |
Enanta Pharmaceuticals, Inc. |
EDP-938 |
zelicapavir |
A nonfusio.. |
Respirator.. |
Phase II |
View Details
|
| PP160728014549 |
Faron Pharmaceuticals Oy |
Clevegen, FP-1305 |
bexmarilimab |
Targeting .. |
Myelodyspl.. |
Phase III, Phase II completed, Phase II, Phase II, Preclinical |
View Details
|
| PP170627015921 |
Evofem Biosciences, Inc., Evofem Inc. |
EVO200 |
|
A vaginal .. |
Prevention.. |
Phase I completed |
View Details
|
| PP181031016784 |
ENTEROME Bioscience |
EO2401 |
|
Targeting .. |
Glioblasto.. |
Phase II completed, Phase II |
View Details
|